J&J Wins Patent Dispute Over Birth Control Drug

Law360, New York (September 11, 2012, 8:42 PM EDT) -- A New Jersey federal judge Tuesday declared valid the patent behind Johnson & Johnson's Ortho Tri-Cyclen Lo birth control drug, blocking a Lupin Pharmaceuticals Inc. effort to market a generic competitor.

U.S. District Judge Stanley R. Chesler rejected Lupin's claims that a patent owned by J&J subsidiary Janssen Pharmaceuticals for the oral contraceptive was invalid as either obvious or anticipated.

The judge struck down a slew of arguments for why the formula wasn't patentable, among them Lupin's claim that a skilled artisan would have found it...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.